Indivior Pharmaceuticals, Inc.
INDV
$34.44
-$0.33-0.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 356.00M | 252.00M | 210.00M | 129.00M | 108.00M |
| Total Depreciation and Amortization | 17.00M | 19.00M | 20.00M | 21.00M | 24.00M |
| Total Amortization of Deferred Charges | 1.00M | -- | -- | 3.00M | 3.00M |
| Total Other Non-Cash Items | 81.00M | 55.00M | 0.00 | 68.00M | 68.00M |
| Change in Net Operating Assets | -495.00M | -437.00M | -257.00M | -44.00M | 15.00M |
| Cash from Operations | -40.00M | -111.00M | -27.00M | 177.00M | 218.00M |
| Capital Expenditure | -71.00M | -81.00M | -66.00M | -58.00M | -45.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 1.00M | 0.00 | 24.00M | 66.00M |
| Cash from Investing | -71.00M | -80.00M | -66.00M | -34.00M | 21.00M |
| Total Debt Issued | 489.00M | 489.00M | -- | 332.00M | 332.00M |
| Total Debt Repaid | -342.00M | -346.00M | -17.00M | -250.00M | -247.00M |
| Issuance of Common Stock | 1.00M | 1.00M | 2.00M | 2.00M | 2.00M |
| Repurchase of Common Stock | -304.00M | -128.00M | -13.00M | -63.00M | -115.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.00M | -22.00M | -2.00M | -6.00M | -5.00M |
| Cash from Financing | -174.00M | -6.00M | -30.00M | 15.00M | -33.00M |
| Foreign Exchange rate Adjustments | -2.00M | -2.00M | -2.00M | -1.00M | 0.00 |
| Miscellaneous Cash Flow Adjustments | -1.00M | 2.00M | 1.00M | 1.00M | 2.00M |
| Net Change in Cash | -288.00M | -197.00M | -124.00M | 158.00M | 208.00M |